Image: Blue Health Intelligence.
€3.4m · Other round · Healthtech · Amsterdam, Netherlands
Amsterdam-based Blue Health Intelligence has raised €3.4m in growth capital to expand its preventive health-check service and develop its digital platform. The company announcement says Knop Investments led the round, with participation from Jeroen Tas and Anna Nooshin.
The €3.4m is the current financing. Blue says it follows an earlier round of more than €1.1m, taking total funding in its first year to about €4.5m. The new capital is intended for expansion in the Netherlands and abroad, as well as further product development.
Scaling a clinic and software together
Blue sells a one-hour, €299 health check at its Amsterdam centre. The appointment combines hundreds of data points across areas including cardiovascular health, metabolism, and liver and kidney function; a doctor discusses the results, which are then available in the company's app. Blue says more than 2,000 people have booked a check and that the Amsterdam site is fully booked through November.
This is not a software-only expansion. Each new market requires a physical location, medical staff, diagnostic equipment and local operating processes before bookings can turn into revenue. The platform can standardise how tests, results and follow-up are handled, but clinic throughput and consistent medical delivery remain central to the model.
That combination shapes the economics. A fuller appointment book can spread fixed location and equipment costs across more customers, while repeat checks can turn a one-off service into a longitudinal health record. Blue's challenge is to preserve the one-hour experience and doctor interaction as volume grows rather than letting capacity constraints weaken the service that attracted demand.
International plans test repeatability
Blue says France and Italy are its priority markets and expects to launch in either Paris or Milan in the first half of 2027. That is a plan, not an operating milestone yet. The company will need to translate its Amsterdam workflow into a new healthcare and labour context, while finding a site that can support sufficient customer volume.
The company also works with TrainMore, Hotel & Wellness Zuiver and Fosbury & Sons Amsterdam. Those partnerships offer distribution alongside direct consumer bookings. The funding therefore backs two connected tests: whether Blue can reproduce its clinic model in another city, and whether its app can keep customers engaged between periodic checks rather than serving only as a results archive.
